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Original article
Cardiovascular disease is the largest cause of morbidity and 
mortality worldwide.1 An exaggerated morning blood pressure 
surge (MBPS), ascertained using ambulatory blood pressure 
monitoring, is thought to be a risk factor for cardiovascular 
disease events occurring in the morning.2,3 This assumption is 
based on a number of prospective studies assessing the associa-
tion between MBPS and subsequent cardiovascular disease.4–8 
However, the prognostic value of MBPS for cardiovascular dis-
ease has been questioned, with more recent studies unable to 
reproduce the findings of earlier work.9,10
One possible cause of this disagreement is the many dif-
ferent definitions and thresholds used to define the MBPS in 
previous studies. For instance, MBPS is commonly defined 
as the sleep-trough surge, calculated by subtracting the 
morning blood pressure (mean of 4 readings over 2 hours 
just after wake-up) from the lowest nocturnal blood pres-
sure (mean of 3 readings centred around the lowest night-
time blood pressure) (Figure 1).2,7 However, it has also been 
defined as the prewaking surge (morning blood pressure 
minus the 4 readings over 2 hours before waking)6,8 and the 
rising blood pressure surge (single morning blood pressure 
reading upon rising minus a single blood pressure reading 
30 minutes before waking)11 among a variety of different 
definitions (Figure 1).12
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background
An exaggerated morning blood pressure surge (MBPS) may be asso-
ciated with stroke and other cardiovascular events, but the threshold 
at which an MBPS becomes pathological is unclear. This study aimed 
to systematically review the existing literature and establish the most 
appropriate definition of pathological MBPS.
methods
A MEDLINE search strategy was adapted for a range of literature data-
bases to identify all prospective studies relating an exaggerated MBPS 
to cardiovascular endpoints. Hazard ratios (HRs) were extracted and 
synthesized using random-effects meta-analysis.
results
The search strategy identified 2,964 unique articles, of which 17 were 
eligible for the study. Seven different definitions of MBPS were iden-
tified; the most common was a prewaking surge (mean blood pres-
sure for 2 hours after wake-up minus mean blood pressure for 2 hours 
before wake-up; n = 6 studies). Summary meta-analysis gave no clear 
evidence that prewaking MBPS (defined by a predetermined threshold: 
>25–55 mm Hg) was associated with all cardiovascular events (n  =  2 
studies; HR = 0.94, 95% confidence interval (CI) = 0.39–2.28) or stroke 
(n = 2 studies; HR = 1.26, 95% CI = 0.92–1.71). However, using a continu-
ous scale, which has more power to detect an association, there was 
evidence that a 10 mm Hg increase in MBPS was related to an increased 
risk of stroke (n = 3 studies; HR = 1.11, 95% CI = 1.03–1.20).
conclusions
These findings suggest that when measured and analyzed as a con-
tinuous variable, increasing levels of MBPS may be associated with 
increased risk of stroke. Large, protocol-driven individual patient data 
analyses are needed to accurately define this relationship further.
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Ambulatory blood pressure monitoring is becoming 
increasingly more common in routine clinical practice and 
has been recommended in the United Kingdom for the rou-
tine diagnosis of hypertension.13,14 With opportunities to 
assess and treat the MBPS increasing, it has never been more 
important to establish the prognostic significance of this 
phenomenon. This study therefore aimed to systematically 
review existing literature and establish the most appropriate 
definition of pathological MBPS, taking into account its rel-
evance to cardiovascular disease morbidity and mortality and 
also the heterogeneity of the differing sample populations 
used in previous studies.
METHODS
Design
This study systematically reviewed all existing lit-
erature relating definitions of the MBPS to cardiovas-
cular disease endpoints. The protocol and registration 
details of this study can be found online (http://www.
crd.york.ac.uk/PROSPERO; registration number 
CRD42012002091).
Search strategy
A search strategy (see Supplementary Table S1) designed 
to capture all studies relating definitions of the MBPS to car-
diovascular disease endpoints was developed for use with 
MEDLINE, and this was adapted to be run across the fol-
lowing additional databases: Cochrane (Wiley) CENTRAL 
Register of Controlled Trials, MEDLINE In Process (Ovid), 
EMBASE (Ovid), CINAHL (EBSCO), Cochrane Database 
of Systematic Reviews (CDSR), Database of Abstracts 
of Reviews of Effects (DARE), and Health Technology 
Assessment Database (HTA). The ZETOC (Mimas) data-
base and Conference Proceedings Citation Index (ISI Web 
of Knowledge) were searched for conference proceedings 
and abstracts. In addition, the Current Controlled Trials 
metaRegister, NIHR Clinical Research Network Portfolio, 
ClinicalTrials.gov, and the World Health Organization 
International Clinical Trials Registry Platform were 
searched to locate any ongoing trials. Searches were car-
ried out up to October 2013. To capture as broad a range 
of studies as possible, no study design filters were used, 
and no language or date limits were applied. In addition 
to searches of electronic databases, reference lists of stud-
ies included in the review were checked to identify further 
potentially relevant papers.
Selection of studies and inclusion criteria
Two reviewers (J.S.  and J.H.) independently reviewed 
the titles and abstracts of potentially relevant articles for 
inclusion. Studies were selected for full document screen-
ing and data extraction provided they fulfilled the follow-
ing inclusion criteria: (i) they were a prospective study; 
(ii) they defined and measured the MBPS; and (iii) they 
examined the relationship between MBPS and subse-
quent cardiovascular disease endpoints. All selected stud-
ies had to include at least 1 measurement of the MBPS in 
each study participant (at baseline, calculated from blood 
pressure measurements made using ambulatory or home 
blood pressure monitoring). No restrictions were made on 
the populations studied or the context in which MBPS was 
measured.
Figure 1. Definitions of morning, nighttime, and evening blood pressure measurements and morning blood pressure surge. This figure has been 
reproduced from Kario, K. (2010). Morning Surge in Blood Pressure and Cardiovascular Risk: Evidence and Perspectives. Hypertension, 56: 765–773.2 
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Data collection
Data were independently extracted from each included 
article by J.S.  and J.H. Differences were resolved by con-
sensus. Extracted data included any information about the 
sample population (e.g., patient demographics, mean blood 
pressure, dipping status, diagnosis of white coat or masked 
hypertension, prescribed medication, and history of car-
diovascular disease and risk factors), the threshold value (if 
used), and definition of MBPS. Because the outcome was 
onset of cardiovascular disease subsequent to the measure-
ment of MBPS, the suitable effect measure to quantify the 
association was a hazard ratio (HR).15 This compares the rel-
ative rate of cardiovascular disease in those with higher com-
pared with lower MBPS values across the entire follow-up 
period. Where HRs were not reported directly, we used the 
methods of Parmar et al.16 to indirectly estimate them from 
other information available (such as a P value and number 
of events in each group). The data extraction sheet used is 
available in the Supplementary Methods.
Assessment of methodological quality
The methodological quality and risk of bias of individ-
ual studies was examined using the checklist described by 
Hayden et al.17 for examining the quality of prognosis stud-
ies in systematic reviews, supplemented by further author-
defined markers of methodological quality, including 
reporting of sampling and study follow-up.
Outcomes
The primary outcome of this review was to establish the 
most appropriate definition of MBPS that best describes its 
association with cardiovascular disease endpoints—spe-
cifically, all stroke events, all cardiovascular disease events, 
and all-cause mortality. Both analyses of MBPS thresholds 
(which define high and low MBPS values) and MBPS on a 
continuous scale were included.
Analysis
The characteristics and population demographics of 
each study were summarized using descriptive statistics. 
Log HR estimates and their confidence intervals (CIs) were 
synthesized into a random-effects meta-analysis using the 
method of DerSimonian and Laird.18 This method allows for 
between-study heterogeneity in the true HRs, and produces 
a pooled HR estimate and 95% CIs to summarize the prog-
nostic association of MBPS for each outcome. There were 
insufficient studies to calculate prediction intervals, to per-
form meta-regression to explore causes of heterogeneity, or 
to investigate small study effects (potential publication bias).
RESULTS
The search strategy identified 4,200 articles, of which 1,236 
were duplicates. Of the remaining 2,964 articles, 133 (4.5%) 
were eligible for full-text screening, from which 17 (0.6%) 
were suitable for data extraction and included in the analy-
sis (Figure  2). Included studies were conducted in 14 differ-
ent countries and examined a total of 33,154 patients with a 
mean age of 60 years (Table 1). Studies differed according to 
sample size (42–11,291 patients), mean age (49–72 years), sex 
(32%–64% women), and the proportion of patients on blood 
pressure–lowering treatment (0%–76%) (Table 1). All studies 
recorded MBPS at baseline, and the majority (n = 11 studies) 
examined hypertensive patients in a secondary care setting. 
Patients were followed up for 37–137 months.
The methodological quality of each study is detailed in 
Table  2. Studies varied in methodological weakness (and 
reporting): all studies described how long patients were 
followed up and all but two described how the population 
was sampled.4–11,19–25 Only 9 of 17 studies reported satis-
factory attrition rates,4,5,7,8,10,11,19,21,24 8 of 17 reported the 
planned sample size,4,7–9,19,21,22,26 and 11 of 17 reported how 
patients were selected for analysis.4,5,7–11,19,21,22,24 Reporting 
of outcome measures was generally good (n  =  14 of 17 
studies),4,11,19,21–25 but reporting of prognostic factor meas-
urement and account of confounding was less satisfactory 
overall (n = 11 of 174,5,7–11,19–22 and 10 of 17 studies,4,6–11,19,24,27 
respectively). Only 9 of 17 studies provided sufficient data 
to allow an HR to be calculated,4,6–11,24,25 which limited the 
number of studies that could be pooled in the meta-analysis. 
It should be noted that those studies included in the meta-
analysis performed well in our assessment of methodologi-
cal quality, other than Dolan et al.,6 which, as an abstract, 
lacked the sufficient detail required to properly examine its 
methodological strengths and weaknesses.
A total of 7 different definitions of MBPS were assessed 
in the included studies (Tables 3 and 4). The most common 
were the sleep-trough surge (n  =  8 studies),4,5,7–10,26,27 pre-
waking surge (n  =  6 studies),4,6–10 and rising surge (n  =  4 
studies).10,11,19,20 Ten studies analyzed MBPS as a categori-
cal variable using a predetermined threshold to define an 
exaggerated MBPS; 4 studies analyzed MBPS as a continu-
ous variable; and 3 studies presented results for MBPS ana-
lyzed as both a categorical and continuous variable (Table 4). 
Thresholds for an exaggerated MBPS varied between studies 
from >12 to >153 mm Hg (Table 4).
Because of the low number of studies eligible for the 
pooled analyses, it was not possible to compare all defini-
tions or thresholds of MBPS or carry out subgroup analyses 
by methodological quality. We focused our pooled analyses 
on studies examining comparable definitions of MBPS. The 
2 most commonly used definitions of MBPS (sleep-trough 
surge and prewaking surge) were therefore pooled in separate 
meta-analyses grouped by outcome variable (Figures 3 and 4). 
There was no evidence of an association between the MBPS, 
defined by a predetermined threshold, and all cardiovascu-
lar events, stroke events, or all-cause mortality (Figure  3). 
However, when the MBPS was analyzed as a continuous vari-
able, a 10 mm Hg increase in the prewaking surge was associ-
ated with an increased risk of all stroke events (n = 3 studies; 
HR = 1.11, 95% CI = 1.03–1.20) (Figure 4). Metoki et al.,8 
which was included in this result, failed to report the unit 
of increase in MBPS associated with stroke events, although 
other analyses reported in this article examined an increase 
of 13.8 mm Hg (1 SD). Even with the removal this study, the 
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association between increasing prewaking surge and stroke 
remained (n  =  2 studies; HR  =  1.11, 95% CI  =  1.02–1.21). 
Only 1 study related the sleep-trough surge to stroke events 
on a continuous scale, and this was also associated with an 
increased risk (HR = 1.25, 95% CI = 1.06–1.48).7
All included studies were adjusted for confound-
ing, but potential sources of bias varied between stud-
ies (Supplementary Table S2). All studies adjusted for 
age and mean systolic blood pressure, and all but 1 
adjusted for sex,7 but only 3 of 6 studies corrected for 
dipping status.4,7,9 The heterogeneity between studies 
was considerable in those examining the association 
between the sleep-trough surge or prewaking surge and 
cardiovascular events (I2  =  91.9%–92.9%; P  <  0.001).4,9 
However, in studies investigating the association between 
the prewaking surge (analyzed as a continuous variable) 
and all stroke events, heterogeneity was low (I2 = 0.0%; 
P = 0.92).6–8
DISCUSSION
This study systematically reviewed all existing literature 
evaluating the association between MBPS and subsequent 
cardiovascular disease. No clear evidence of an associa-
tion between MBPS and all cardiovascular disease or stroke 
events or all-cause mortality was found when the surge was 
Figure 2. Selection of studies to include in analysis of the effect of an exaggerated morning blood pressure surge (MBPS) on cardiovascular morbidity 
and mortality. Abbreviation: CVD, cardiovascular disease.
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defined by a predetermined threshold, confirming the find-
ings of recent prospective studies.9,10 However, using a con-
tinuous variable to describe the morning surge, there was 
evidence of an association with all stroke events in patients 
with hypertension: for every 10 mm Hg increase in (prewak-
ing) MBPS, the risk of stroke also increased by 11%. This 
suggests that the relationship between MBPS and outcome 
is more complex than can be identified simply using a sin-
gle threshold and is perhaps unsurprising given that analysis 
of candidate continuous predictors on their original scale 
has more power and is less prone to bias than dichotomiza-
tion.28,29 However, given the paucity and quality of studies 
examining the MBPS in this way, further work is needed, 
perhaps through reanalysis of existing data, before definitive 
recommendations for clinical practice can be made.
This study used a thorough and extensive search strategy 
in a large number of research literature databases to capture 
existing prospective studies relating MBPS to cardiovascu-
lar disease endpoints. Despite screening a large number of 
potentially relevant studies (n = 2,964), only 17 articles ful-
filled the study inclusion criteria, and only 6 of these could be 
pooled in a meta-analysis. This limited the extent to which 
different definitions and thresholds of MBPS could be com-
pared as originally planned. This was particularly evident in 
the assessment of the MBPS as a continuous variable, where 
only the association between the prewaking surge and all 
stroke events was examined by >1 study and the 2 largest, 
highest quality studies4,9 could not be included.
Not all of the studies included in our pooled analyses were 
directly comparable. Most dichotomized the sample popula-
tion by a particular threshold level of MBPS and compared 
those with an exaggerated MBPS against the rest of the popu-
lation. The choice of threshold often differed across studies, 
as would be expected given that a pathological MBPS differs 
by various factors such as hypertensive status, age, and eth-
nicity.2 These meta-analysis results relate to the association 
at some average threshold value, which may go some way to 
explaining why the association between exaggerated MBPS 
and cardiovascular disease was not significant when data were 
examined in this way.
The study by Verdecchia et al.9 divided the sample popu-
lation into quartiles by level of MBPS and individually com-
pared patients with an exaggerated MBPS against those from 
each of the 3 other quartiles of MBPS level. In our pooled 
analyses, HRs comparing those with an exaggerated MBPS 
against those with a minimal MBPS (lowest quartile of MBPS) 
were used. Thus the estimates of association between MBPS 
and cardiovascular endpoints from this study are likely to be 
more pronounced compared with that seen in other studies. It 
should also be noted that there were differences in the adjust-
ment for other prognostic factors (confounders) used across 
studies (Supplementary Table S2). Despite this, it is a strength 
that studies adjusted for multiple variables, thus allowing the 
independent prognostic association for MBPS and outcome 
to be summarized.
One study included in our pooled analyses was that 
of Li et  al.,4 which examined data from the International 
Database of Ambulatory Blood Pressure in Relation to 
Cardiovascular Outcome.30 This database includes patients 
from studies conducted around the world, including those 
from the Ohasama Study31 and the Allied Irish Bank 
study.32 It is possible that these same patients may have 
been included in other studies identified by this review,6,8 
although it was not possible to confirm this from the data 
available. This potential overlap only affected analyses of 
the association between sleep-trough prewaking surge and 
stroke events (examined using a threshold to define exag-
gerated MBPS) (Figure 3), neither of which showed signifi-
cant results, and thus the impact on the overall findings of 
this study are likely to be minimal.
Our study did not explicitly set out to consider the influ-
ence of nocturnal dipping status on cardiovascular disease 
risk, although some studies included in the meta-analysis did 
adjust their findings for dipping status in the sample popula-
tion (Supplementary Table S2).4,6,7 A lack of nocturnal dip is 
considered to be a significant independent risk factor for car-
diovascular disease, despite such patients having only a small 
MBPS. This apparent contradiction may explain some of the 
inconsistences in association between MBPS and cardiovas-
cular disease observed here. This review was not designed to 
Table 3. Definitions of morning blood pressure surge studied in included articles
Morning blood pressure  
surge description Definition
Sleep-trough surge Morning blood pressure (average of 2 hours of readings after wake-up) minus the lowest 
nighttime reading (average of the lowest nighttime reading and the 2 adjacent readings before 
and after)
Prewaking surge Morning blood pressure (average of 2 hours of readings after wake-up) minus the pre-awake 
blood pressure (average of 2 hours of readings before wake-up)
Rising surge Blood pressure on rising (single reading after wake-up) minus blood pressure before wake-up 
(single reading before wake-up)
Morning nighttime difference Two morning blood pressure readings (after 7 am) minus the average nighttime blood 
pressure
Morning blood pressure Average morning blood pressure for 2 hours after wake-up
Morning evening difference Morning blood pressure (average of self-monitored blood pressure readings taken in the 
morning) minus evening blood pressure (average of self-monitored blood pressure readings 
taken in the evening)
Morning blood pressure power The product of the rate of the rise (change over time) and the amplitude (day–night 
difference) of morning blood pressure
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compare the associations of MBPS and nocturnal dipping 
status with cardiovascular disease, but future work should 
consider these associations together, rather than in isolation.
The exaggerated MBPS was originally proposed as a prog-
nostic factor for stroke in 2003.7 In a group of 519 elderly 
hypertensive patients, it was shown that a 10 mm Hg increase 
in MBPS resulted in a 25% increased risk of clinical stroke 
events, and the authors proposed a sleep-trough MBPS of 
>55 mm Hg as pathological. A subsequent review,2 published 
in 2010, summarized the existing literature relating specific 
thresholds of MBPS to cardiovascular endpoints and con-
cluded that it was an important risk factor. Since then, more 
recent studies have shown contradictory findings,9,10 and 
the inclusion of these and others19,21,23–27 in our review has 
resulted in subtly different conclusions: namely, that although 
there was no significant association between MBPS above a 
predetermined threshold and increased risk of cardiovas-
cular disease, there was evidence of a relationship between 
increasing levels of MBPS (analyzed on a continuous scale) 
and increased risk of stroke events in hypertensive patients. 
This finding is perhaps not surprising given that analysis of 
candidate continuous predictors on their original scale has 
more power to detect associations with a given outcome 
variable.28,29
This issue is also pertinent in the diagnosis of hyperten-
sion, where for many years, high blood pressure has been 
defined as blood pressure above a specific threshold,33 
despite the linear relationship between cardiovascular dis-
ease risk and increasing blood pressure.34 The appropri-
ate threshold for treatment of hypertension has long been 
debated35 without worldwide consensus.14,36,37 Indeed, some 
have suggested that thresholds should be abandoned in favor 
of a risk-based approach,38 and this has been adopted in 
Australia36 and New Zealand.37
MBPS is an important concept in clinical practice, not 
least because it has been proposed as a cause of wake-up 
stroke,2,3 which is not amenable to treatment with thrombol-
ysis because of lack of knowledge of onset time.39 Identifying 
MBPS is now realistic with the increased uptake of ambula-
tory blood pressure monitoring in routine clinical practice.14 
This study found some evidence that an increasing MBPS 
is associated with an increased stroke risk, and conceivably 
Figure 3. Forest plot of adjusted hazard ratios (HRs) depicting the risk of cardiovascular morbidity and/or mortality with an exaggerated morning blood 
pressure surge. Data were analyzed as categorical variables (using a threshold value to define an exaggerated morning blood pressure surge).
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this could allow inclusion in risk calculation tools. However, 
because of the limited number of studies, this finding requires 
further investigation. Indeed, of the 3 studies that analyzed 
the data in this way, 1 was only published as a conference 
proceeding and the remaining 2 studies were conducted in 
Japanese populations where the risk of stroke is high; thus 
the generalizability of these findings is unclear. Further work 
could involve reanalysis of existing patient data from pre-
vious studies in an individual patient data meta-analysis.40 
Should future studies confirm an increasing MBPS as a 
prognostic factor for cardiovascular disease, more thought 
will be required to establish how such a marker can be used 
effectively (i.e., at what point should treatment regimens 
be adjusted to account for increasing MBPS) given that for 
diagnosis and treatment decisions, markers using predeter-
mined thresholds are easier to implement in routine clinical 
practice.
This study found some evidence that increasing levels of 
MBPS are associated with increased risk of stroke. This was 
only the case when the MBPS was measured and analyzed as a 
continuous variable, perhaps because of the increased power to 
detect associations with the specified outcome variable. Further 
studies examining MBPS in this way are needed to accurately 
define this relationship to inform routine clinical practice.
SUPPLEMENTARY MATERIAL
Supplementary materials are available at American Journal 
of Hypertension (http://ajh.oxfordjournals.org).
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